Senior Manager, HTA, Value and Evidence (HV&E), Rare Disease

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines.The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making.ROLE SUMMARYThe HTA, Value & Evidence Senior Manager is responsible for development and execution of high-quality HV&E strategic efforts to support optimal access and reimbursement for treatments in Rare Disease. This role directly impacts business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of Rare Disease medicines.This position will be part of Pfizer’s dynamic US Medical Affairs/HV&E team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to Rare Disease with a primary focus on Hympavzi/Vyndaqel and SCD. This position will be working closely with cross-functional teams (e.g., access, medical, clinical, commercial, etc.) to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general. This position will function in a closely aligned fashion with the Access team to ensure there is a single and coordinated view on strategy and project execution.This position will function with a One Pfizer mindset and will be expected to partner with Pfizer colleagues in various regional and national markets to ensure a consistent and robust evidence generation strategy.ROLE RESPONSIBILITIES Support the development of the Global HTA Value & Evidence Strategy in close partnership with Access and the cross-functional teamManage execution of clinically relevant and scientifically valid Value & Evidence studies and projects (including non-interventional studies, registries, etc.) in alignment with the Global Value & Evidence Strategy to demonstrate the value proposition catered to diverse stakeholders (regulators, payers, patients, physicians, and policy makers)Lead updates of tools including global value dossiers (GVDs), economic models, and innovative tools to support value propositionDevelop real world evidence generation strategies and execute studies to support brand differentiation and value propositionLead the coordination of input from local country/regional Access & Value teams on evidence needs and ensure that input is appropriately incorporated to support demonstration of product value and optimize patient accessLead the development of data dissemination plans and communicate, in a timely manner, evidence generated for various stakeholders via publications and conference presentationsProvide leadership on projects to ensure timely execution of PRO/PCOA research to characterize patient outcomes, identify patient preferences and unmet needs, inform patient-focused measurement strategies, and develop and validate innovative patient-relevant outcomes measures and endpoints to differentiate Pfizer’s portfolio and meet business and global needs.Ensures the scientific quality and integrity of PRO research through development of rigorous qualitative and quantitative study research proposals, protocols, analysis plans and reports.BASIC QUALIFICATIONSCandidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.Graduate degree (e.g., MSc, MPH, PhD, DrPH) in HEOR-relevant field such as health services research, health economics, epidemiology, pharmacy administration/pharmaceutical policy, or other research-focused public health field.Minimum 5 years of years of experience with MSc/MPH/MBA degree; ≥ 1 years with PharmD/PhD/DrPH in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)Advanced understanding of HEOR concepts, fundamental health services research methods (e.g., health economics, patient reported outcomes, research study design, database analyses, epidemiology, and statistics), data interpretation and external environmental trends influencing health care/pharmaceuticals in key markets worldwideStrong project management skills (contracting, budgeting, vendor management)Demonstrated ability to oversee small project teams and leadership exposureDemonstrated advanced understanding of project execution, ability to manage multiple projects involving complex processes, significant budget, competing deadlines and rapidly shifting prioritiesExcellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environmentExcellent oral and written English communication skills requiredSkilled in functioning within a matrix organization where managing through influence is requiredPREFERRED QUALIFICATIONSExperience with clinical trials, patient reported outcomes, and real-world study design and implementation desirableKnowledge and experience in rare diseaseExperience in the biotech/pharmaceutical industryOther Job Details:Last Date to Apply for Job: June 23Locations: NYHQ; PA - Collegeville; MA - Cambridge; Europe - Any Pfizer siteAbility to travel domestically and internationally based on business needsAbility to work in all US time zonesNOT eligible for Relocation PackageThis position is hybrid and requires working onsite 2 to 3 days per week The annual base salary for this position ranges from $139,100.00 to $231,900.0